Filippo Sean Giorgi Selected Research

Filippo Sean Giorgi Research Topics

Disease

7	Epilepsy (Aura) 01/2022 - 11/2014
7	Alzheimer Disease (Alzheimer's Disease) 11/2021 - 03/2017
5	Seizures (Absence Seizure) 03/2022 - 09/2007
4	Partial Epilepsies (Epilepsy, Partial) 12/2021 - 01/2015
4	Neuroinflammatory Diseases 01/2021 - 11/2019
3	Dementia (Dementias) 01/2021 - 10/2017
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 01/2019
2	Status Epilepticus (Complex Partial Status Epilepticus) 03/2022 - 01/2022
2	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2009
2	Juvenile Myoclonic Epilepsy 01/2021 - 11/2019
2	Frontotemporal Dementia (Semantic Dementia) 01/2020 - 10/2017
2	Cognitive Dysfunction 02/2018 - 09/2007
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Autism Spectrum Disorder 11/2021
1	Mental Disorders (Mental Disorder) 11/2021
1	Movement Disorders (Movement Disorder) 10/2021
1	Lewy Body Disease (Lewy Body Dementia) 01/2021
1	Neoplasms (Cancer) 01/2020
1	Carcinogenesis 01/2020
1	Epileptic Syndromes 11/2019
1	Generalized Epilepsy 11/2019
1	Gliosis 11/2019
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2019
1	Catatonia 01/2018
1	Hemorrhage 01/2018
1	Infections 09/2017
1	Communicable Diseases (Infectious Diseases) 09/2017
1	Phenylketonurias (Phenylketonuria) 01/2014
1	Drug Resistant Epilepsy 08/2003

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2009
6	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022 - 01/2015
6	Biomarkers (Surrogate Marker)IBA 11/2020 - 11/2014
4	brivaracetamIBA 01/2022 - 09/2017
4	Amyloid (Amyloid Fibrils)IBA 11/2021 - 09/2019
3	Levetiracetam (Keppra)FDA LinkGeneric 01/2022 - 09/2017
3	EnzymesIBA 11/2021 - 10/2020
2	BicucullineIBA 03/2022 - 11/2014
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2022 - 11/2020
2	Sirolimus (Rapamycin)FDA Link 01/2022 - 06/2015
2	Pharmaceutical PreparationsIBA 12/2021 - 01/2018
2	Valproic Acid (Depakote)FDA LinkGeneric 01/2021 - 09/2017
2	Lamotrigine (Lamictal)FDA LinkGeneric 01/2021 - 09/2017
2	SynucleinsIBA 01/2021 - 09/2019
2	tau Proteins (tau Protein)IBA 01/2020 - 10/2017
1	Adrenergic Receptors (Adrenergic Receptor)IBA 03/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	AMPA Receptors (AMPA Receptor)IBA 01/2022
1	NeuregulinsIBA 11/2021
1	Biological ProductsIBA 11/2021
1	Dopamine (Intropin)FDA LinkGeneric 10/2021
1	ImmunosorbentsIBA 01/2021
1	Pattern Recognition ReceptorsIBA 11/2020
1	CytokinesIBA 11/2020
1	Ion Channels (Ion Channel)IBA 01/2020
1	LigandsIBA 01/2020
1	ProgranulinsIBA 01/2020
1	Glutamic Acid (Glutamate)FDA Link 01/2020
1	gamma-Aminobutyric Acid (GABA)IBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	GABA-A Receptors (GABA(A) Receptor)IBA 01/2020
1	Adrenergic Agents (Adrenergic Drugs)IBA 11/2019
1	Immunoglobulin E (IgE)IBA 11/2019
1	InterleukinsIBA 11/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2019
1	AntioxidantsIBA 02/2018
1	LithiumIBA 01/2018
1	Dabigatran FDA Link 01/2018
1	RivaroxabanIBA 01/2018
1	edoxabanIBA 01/2018
1	AnticoagulantsIBA 01/2018
1	apixabanIBA 01/2018
1	Amyloid beta-PeptidesIBA 10/2017
1	Zonisamide (Zonegran)FDA LinkGeneric 09/2017
1	Phenytoin (Dilantin)FDA LinkGeneric 09/2017
1	perampanelIBA 09/2017
1	remacemideIBA 09/2017
1	Pregabalin (Lyrica)FDA Link 09/2017
1	ezogabine (retigabine)IBA 09/2017
1	rufinamide FDA Link 09/2017
1	Gabapentin (Neurontin)FDA LinkGeneric 09/2017
1	Tiagabine (Gabitril)FDA Link 09/2017
1	Topiramate (Topamax)FDA LinkGeneric 09/2017
1	Lacosamide FDA Link 09/2017
1	Oxcarbazepine (Trileptal)FDA LinkGeneric 09/2017
1	Thyroid HormonesIBA 03/2017
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 11/2014
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2014
1	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 09/2007

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2020
1	Chemoradiotherapy 01/2022
1	Precision Medicine 01/2018
1	Vagus Nerve Stimulation 08/2003